Camp4 Therapeutics (CAMP) Interest & Investment Income (2023 - 2026)
Camp4 Therapeutics (CAMP) reported Interest & Investment Income of $910000.0 for Q1 2026, up 54.76% on a YoY basis from $588000.0 in Q1 2025, and up 28.17% sequentially from $710000.0 in Q4 2025.
Camp4 Therapeutics (CAMP) Interest & Investment Income (2023 - 2026) Analysis & Trends
Camp4 Therapeutics (CAMP) has 4 years of Interest & Investment Income data on file, last reported at $910000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 54.76% year-over-year to $910000.0; the trailing twelve-month figure through Mar 2026 stood at $2.5 million (up 63.89% YoY), and the FY2025 full-year result was $2.2 million, up 63.46% from the prior year.
- Interest & Investment Income rose to $910000.0 in Q1 2026, from $710000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $910000.0 in Q1 2026 to a low of $94000.0 in Q3 2024.
- A 4-year average of $515636.4 and a median of $569000.0 in 2023 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income slumped 86.36% in 2024 and surged 350.0% in 2025, its largest moves.
- Tracing CAMP's Interest & Investment Income over 4 years: stood at $569000.0 in 2023, then gained by 7.21% to $610000.0 in 2024, then advanced by 16.39% to $710000.0 in 2025, then increased by 28.17% to $910000.0 in 2026.
- Business Quant data shows CAMP's Interest & Investment Income at $910000.0 in Q1 2026, $710000.0 in Q4 2025, and $423000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Camp4 Therapeutics | 195.78 Mn | 195.78 Mn | - | 910,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 910,000.00 |
| Dec 31, 2025 | 710,000.00 |
| Sep 30, 2025 | 423,000.00 |
| Jun 30, 2025 | 453,000.00 |
| Mar 31, 2025 | 588,000.00 |
| Dec 31, 2024 | 610,000.00 |
| Sep 30, 2024 | 94,000.00 |
| Jun 30, 2024 | 231,000.00 |
| Mar 31, 2024 | 395,000.00 |
| Dec 31, 2023 | 569,000.00 |
| Sep 30, 2023 | 689,000.00 |